Xtrackers MSCI Europe Hedged Equity ETF (DBEU)

Key Metrics

TER 0.45% per year

Distribution policy Distributing

Fund size USD 773 M

Inception date October 1, 2013

Holdings 439

Fund currency USD

Fund domicile US

Provider Xtrackers

For full official fund details, factsheets, and holdings, visit etf.dws.com (opens in new tab).

Historical Return

Last updated: Aug 01, 2026

1 Year +24.0% +4.0% Div

3 Years (avg.) +14.1% +4.0% Div

5 Years (avg.) +9.4% +4.0% Div

Risk & Analysis Metrics

Last updated: Aug 01, 2026

Volatility

12.39% 1 Year

13.42% 3 Years

14.35% 5 Years

16.36% 10 Years

Max Drawdown

-9.68% 1 Year

-15.35% 3 Years

-19.01% 5 Years

-34.50% 10 Years

Sharpe Ratio

1.27 1 Year

0.68 3 Years

0.38 5 Years

0.28 10 Years

Return Triangle (Heatmap)

Last updated: Aug 01, 2026

	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
2013	5.4%	2.2%	0.9%	0.6%	2.5%	0.0%	3.0%	2.0%	3.9%	2.4%	3.1%	3.6%	4.5%
2014		-0.9%	-1.2%	-0.9%	1.8%	-1.0%	2.7%	1.5%	3.7%	2.1%	2.9%	3.5%	4.5%
2015			-1.5%	-1.0%	2.7%	-1.0%	3.4%	1.9%	4.3%	2.5%	3.4%	3.9%	5.0%
2016				-0.4%	4.9%	-0.9%	4.6%	2.6%	5.3%	3.1%	4.0%	4.5%	5.6%
2017					10.5%	-1.1%	6.4%	3.4%	6.5%	3.7%	4.6%	5.2%	6.3%
2018						-11.6%	4.4%	1.1%	5.6%	2.4%	3.7%	4.4%	5.8%
2019							23.2%	8.1%	12.0%	6.2%	7.0%	7.4%	8.5%
2020								-5.1%	6.7%	1.1%	3.3%	4.5%	6.3%
2021									20.1%	4.3%	6.3%	7.0%	8.7%
2022										-9.4%	0.0%	3.0%	6.0%
2023											10.4%	9.8%	11.7%
2024												9.1%	12.4%
2025													15.8%

Distributions

*by ETF Portfolio Weight Last updated: Aug 01, 2026

Profit Margin Distribution

< 0%

1y 3y N/A N/A

0 - 5%

10%

1y 3y N/A N/A

5 - 10%

16%

1y 3y N/A N/A

10 - 15%

17%

1y 3y N/A N/A

15 - 20%

17%

1y 3y N/A N/A

20 - 30%

22%

1y 3y N/A N/A

30 - 40%

1y 3y N/A N/A

> 40%

1y 3y N/A N/A

P/E Ratio Distribution

< 0

1y 3y N/A N/A

0 - 10

1y 3y N/A N/A

10 - 15

20%

1y 3y N/A N/A

15 - 20

19%

1y 3y N/A N/A

20 - 25

21%

1y 3y N/A N/A

25 - 35

1y 3y N/A N/A

35 - 50

1y 3y N/A N/A

> 50

13%

1y 3y N/A N/A

Discounted Cash Flow

Weighted Average Undervaluation

N/A

Undervalued

> 60%

1y 3y N/A N/A

45 - 60%

1y 3y N/A N/A

30 - 45%

1y 3y N/A N/A

15 - 30%

1y 3y N/A N/A

Fair (±15%)

1y 3y N/A N/A

Overvalued

15 - 30%

1y 3y N/A N/A

30 - 45%

1y 3y N/A N/A

45 - 60%

1y 3y N/A N/A

> 60%

1y 3y N/A N/A

Market Cap Size Distribution

Micro Cap

2.2%

1y 3y N/A N/A

Small Cap

6.5%

1y 3y N/A N/A

Mid Cap

12.7%

1y 3y N/A N/A

Large Cap

51.7%

1y 3y N/A N/A

Mega Cap

26.9%

1y 3y N/A N/A

Micro: < $300M Small: $300M–$2B Mid: $2B–$10B Large: $10B–$200B Mega: > $200B

Average metrics of all companies in portfolio

Last updated: Aug 02, 2026

Market
Average

Market Cap The market value of the company. It's calculated by multiplying the share price by the number of outstanding shares.	$154B	-
Dividend Yield Yearly payout to shareholders per share. The percentage indicates the payout in relation to the share price.	2.27%	2.01%
Beta Indicates the relationship between the price performance of a share and the market.	0.84	-
P/E Ratio Ratio between share price and earnings per share. A low ratio could indicate that the stock is undervalued or investors aren't expecting high growth. A high ratio could indicate that the stock is overvalued or investors are expecting high growth.	24.51	30.76
Negative P/E Ratio a negative P/E ratio shows that the company is not profitable, and it shows how many years it would take the company to lose its entire market capitalisation if it did not change anything	-29.8	-
Profitable Companies	93%	-
PEG The ratio between the P/E ratio and the growth rate of the company's earnings per share in the last twelve months. A lower PEG could mean that a stock is undervalued.	27.65	9.33
Price to Sales Ratio Market cap divided by the revenue in the most recent year.	3.94	7.93
Price to Book Ratio Price to Book Ratio is the Market cap divided by the Book value of the company	5.48	10.19

Market
Average

Enterprise Value to EBIT Enterprise Value divided by EBIT	19.18	18.56
Enterprise Value to Revenue Enterprise value divided by revenue	4.52	7.93
Total Debt to Enterprise Value Total debt divided by enterprise value	0.3	0.04
Debt to Equity A higher ratio indicates a higher risk. However, the ratio is difficult to compare between industries where common amounts of debt vary.	1.27	0.29
Profit Margin Net income divided by revenue of the last 4 quarters. It indicates the company's profitability.	12.47%	21.90%
Quarterly Earnings Growth (YoY) The rate at which the company's net income has increased to the same quarter one year ago.	+13.2%	-116.0%
Return on Equity Equity divided by market cap.	23.74%	2.81%
Return on Assets Indicates a company's profitability in relation to its total assets.	7.37%	4.15%
Return on Invested Capital Return on invested capital (ROIC) is net income after dividends divided by the sum of debt and equity. It shows how effective a company is at turning capital invested by shareholders and other debtholders into profits.	14.06%	3.82%

Sectors

Manufacturing	19.6%
Finance and Insurance	8.1%
Mining, Quarrying, and Oil and Gas Extraction	4.8%
Health Technology	4.8%
Information	4.6%
Finance	4.3%
Consumer Non-Durables	1.8%
Utilities	1.2%
Energy	1.2%
Transportation and Warehousing	1.1%
Retail Trade	0.5%
Financial Services	0.4%
Professional, Scientific, and Technical Services	0.3%
Industrials	0.3%
Real Estate and Rental and Leasing	0.3%
Administrative and Support and Waste Management and Remediation Services	0.3%
Wholesale Trade	0.3%
Communications	0.2%
Health Care and Social Assistance	0.2%
Electronic Technology	0.1%
Construction	0.1%
Healthcare	0.1%
Other	45.3%

Countries

United Kingdom	21.0%
Switzerland	15.4%
France	13.3%
Germany	13.1%
Netherlands	10.2%
Spain	5.8%
Sweden	5.1%
Italy	4.9%
Denmark	2.6%
Finland	1.7%
Other	1.6%
Belgium	1.3%
Ireland	1.0%
Norway	1.0%
Austria	0.6%
Luxembourg	0.4%
United States	0.4%
Portugal	0.3%
Hong Kong	0.3%
Mexico	0.0%
Czech Republic	0.0%

Limit holdings to companies in a single sector.

$0B >$1T

Ratio between share price and earnings per share. A low ratio could indicate undervaluation.

<0 >50

Ratio of dividends in the last 12 months to current share price.

0% 3%

Revenue increase compared to the same quarter one year ago.

0% 30%

Net income increase compared to the same quarter one year ago.

0% 30%

Profitability of the last quarter.

<-30% >30%

A higher ratio indicates a higher risk. The ratio is difficult to compare between industries.

<0 >3

Discounted cash flow valuation vs. current price. Positive = undervalued, negative = overvalued.

<-50% >+100%

Market Cap

P/E Ratio

Total Investment

Weight

ASML Holding NV - New York Shares

ASML - Manufacturing

Market Cap $627.85B

P/E Ratio 52.0

Dividends 0.5%

Total Investment $33.67M

Weight 4.36%

Loading details…

HSBC Holdings plc - ADR

HSBC - Finance

Market Cap $365.74B

P/E Ratio 17.4

Dividends 3.5%

Total Investment $17.32M

Weight 2.24%

Loading details…

Roper Technologies Inc

ROP - Manufacturing

Market Cap $39.56B

P/E Ratio 16.3

Dividends 0.9%

Total Investment $15.93M

Weight 2.06%

Loading details…

Astrazeneca plc - ADR

AZN - Health Technology

Market Cap $294.4B

P/E Ratio 25.3

Dividends 1.9%

Total Investment $15.1M

Weight 1.95%

Loading details…

Novartis AG - ADR

NVS - Health Technology

Market Cap $301.3B

P/E Ratio 23.8

Dividends 2.9%

Total Investment $14.85M

Weight 1.92%

Loading details…

Royal Dutch Shell Plc - ADR (Representing Ordinary Shares - Class A)

RDS.A - Mining, Quarrying, and Oil and Gas Extraction

Market Cap

P/E Ratio

Dividends

Total Investment $12.67M

Weight 1.64%

Loading details…

Sap SE - ADR

SAP - Information

Market Cap $213.96B

P/E Ratio 23.0

Dividends 1.6%

Total Investment $10.15M

Weight 1.31%

Loading details…

Banco Santander S.A. - ADR

SAN - Finance and Insurance

Market Cap $206.96B

P/E Ratio 11.1

Dividends 1.9%

Total Investment $9.62M

Weight 1.24%

Loading details…

TotalEnergies SE - ADR

TTE - Energy

Market Cap $195.66B

P/E Ratio 10.9

Dividends 4.4%

Total Investment $9.28M

Weight 1.20%

Loading details…

Suncor Energy, Inc.

SU - Manufacturing

Market Cap $79.44B

P/E Ratio 17.9

Dividends 2.5%

Total Investment $9.27M

Weight 1.20%

Loading details…

Autoliv Inc.

ALV - Manufacturing

Market Cap $9.02B

P/E Ratio 14.4

Dividends 2.8%

Total Investment $9.08M

Weight 1.17%

Loading details…

ABB Ltd. - ADR

ABB - Manufacturing

Market Cap $69.02B

P/E Ratio 35.5

Dividends 1.2%

Total Investment $9.02M

Weight 1.17%

Loading details…

UBS Group AG - Registered Shares

UBS - Finance

Market Cap $172.87B

P/E Ratio 22.9

Dividends 2.0%

Total Investment $8.09M

Weight 1.05%

Loading details…

Energizer Holdings Inc

ENR - Manufacturing

Market Cap $1.44B

P/E Ratio 7.6

Dividends 5.7%

Total Investment $7.93M

Weight 1.03%

Loading details…

Novo Nordisk - ADR

NVO - Manufacturing

Market Cap $209.19B

P/E Ratio 11.2

Dividends 3.8%

Total Investment $7.91M

Weight 1.02%

Loading details…

Moelis & Co - Ordinary Shares - Class A

MC - Finance and Insurance

Market Cap $4.99B

P/E Ratio 22.1

Dividends 3.9%

Total Investment $7.37M

Weight 0.95%

Loading details…

Banco Bilbao Vizcaya Argentaria S.A. - ADR

BBVA - Finance and Insurance

Market Cap $154.43B

P/E Ratio 12.5

Dividends 3.3%

Total Investment $7.1M

Weight 0.92%

Loading details…

AAR Corp.

AIR - Manufacturing

Market Cap $5.59B

P/E Ratio 28.7

Dividends 0.0%

Total Investment $6.69M

Weight 0.87%

Loading details…

British American Tobacco Plc - ADR

BTI - Consumer Non-Durables

Market Cap $130.82B

P/E Ratio 15.7

Dividends 5.3%

Total Investment $6.67M

Weight 0.86%

Loading details…

Unilever plc - ADR

UL - Consumer Non-Durables

Market Cap $136.6B

P/E Ratio 21.5

Dividends 3.6%

Total Investment $6.64M

Weight 0.86%

Loading details…

Key Metrics

Compare similar ETFs

Historical Return

Risk & Analysis Metrics

Volatility

Max Drawdown

Sharpe Ratio

Return Triangle (Heatmap)

Distributions

Profit Margin Distribution

P/E Ratio Distribution

Discounted Cash Flow

Market Cap Size Distribution

Portfolio Concentration

Latest News

More Biotech M&A Is on the Way, Whether an AstraZeneca-Bristol Myers Deal Happens or Not

Top Healthcare Analyst: A $400 Billion AstraZeneca-Bristol Myers Deal Could “Cut Costs in a Big Way”

AstraZeneca-Bristol Myers Merger Buzz Puts Patent Expiration and Deal Economics in Focus

Average metrics of all companies in portfolio

Sectors

Countries

Stock Screener

ASML Holding NV - New York Shares

ASML Holding NV - New York Shares

HSBC Holdings plc - ADR

HSBC Holdings plc - ADR

Roper Technologies Inc

Roper Technologies Inc

Astrazeneca plc - ADR

Astrazeneca plc - ADR

Novartis AG - ADR

Novartis AG - ADR

Royal Dutch Shell Plc - ADR (Representing Ordinary Shares - Class A)

Royal Dutch Shell Plc - ADR (Representing Ordinary Shares - Class A)

Sap SE - ADR

Sap SE - ADR

Banco Santander S.A. - ADR

Banco Santander S.A. - ADR

TotalEnergies SE - ADR

TotalEnergies SE - ADR

Suncor Energy, Inc.

Suncor Energy, Inc.

Autoliv Inc.

Autoliv Inc.

ABB Ltd. - ADR

ABB Ltd. - ADR

UBS Group AG - Registered Shares

UBS Group AG - Registered Shares

Energizer Holdings Inc

Energizer Holdings Inc

Novo Nordisk - ADR

Novo Nordisk - ADR

Moelis & Co - Ordinary Shares - Class A

Moelis & Co - Ordinary Shares - Class A

Banco Bilbao Vizcaya Argentaria S.A. - ADR

Banco Bilbao Vizcaya Argentaria S.A. - ADR

AAR Corp.

AAR Corp.

British American Tobacco Plc - ADR

British American Tobacco Plc - ADR

Unilever plc - ADR

Unilever plc - ADR

Cookie Settings